Nautilus Biotechnology, Inc.

Developing a proteomics platform for single-molecule analysis to advance life sciences research.

NAUT | NDAQ

Overview

Corporate Details

ISIN(s):: US63909J1088
LEI:
Country:: United States of America
Address:: 2701 EASTLAKE AVE EAST, 98102 SEATTLE
Website:: https://www.nautilus.bio/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Nautilus Biotechnology, Inc. is a development-stage life sciences company focused on revolutionizing the field of proteomics. The company is creating a platform to analyze and quantify the human proteome with single-molecule resolution at a massive scale. Its proprietary technology leverages a method called Iterative Mapping to provide high-resolution views of billions of individual protein molecules and their modified forms (proteoforms). Nautilus aims to democratize proteomics by offering an integrated system with accessible workflows and cloud-based analysis tools. The platform is designed to accelerate breakthroughs in drug discovery, biomarker identification, and fundamental biological research by providing clearer insights into the mechanisms of health and disease.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nautilus Biotechnology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nautilus Biotechnology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Nautilus Biotechnology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
NFL Biosciences Develops botanical drug candidates to treat smoking and alcohol addictions.	France	ALNFL
NGS Group Nordic staffing & recruitment for healthcare, education, and social services sectors.	Sweden	NGS
Nihon M&A Center Holdings Inc. M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.	Japan	2127
Noile-Immune Biotech Inc. Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.	Japan	4893
NRGene Technologies Ltd. AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.	Israel	NRGN
Nuvectis Pharma, Inc. Clinical-stage biopharma developing precision medicines for serious oncological conditions.	United States of America	NVCT
Nykode Therapeutics ASA Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.	Norway	NYKD
Ocugen, Inc. Develops gene/cell therapies and vaccines, specializing in blindness and public health.	United States of America	OCGN
Oculis Holding AG Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.	Switzerland	OCS
OKYO Pharma Ltd Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.	United States of America	OKYO